October 2, 2026


7:00 AM - 8:00 AM

Breakfast / Registration


8:00 AM - 8:05 AM

Welcome & Introductions
John T. Cole, MD, FACP


8:05 AM - 8:50 AM

Prevention for Colorectal including Nous 209
Jason Willis, MD, PhD - UT MD Anderson


8:50 AM - 9:30 AM

ctDNA Defined MRD - Clinical Utility in Colorectal Cancer
Brian Kann, MD


9:30 AM - 10:00 AM

Break/Visit Exhibits


10:00 AM - 10:45 AM

Multi-Cancer Detection
Marc Matrana, MD


10:45 AM - 11:30 AM

AI
Jason Hill, MD


11:30 AM - 12:00 PM

Genetic Counseling
Jen Jacober, MS, MPH, CGC


12:00 PM - 1:00 PM

Lunch


1:00 PM - 1:45 PM

MRD (response monitoring and occurrence evaluation)
Arnab Basu, MBBS, MPH, FACP


1:45 PM - 2:30 PM

Biomarker Directed Therapy in Hormone Sensitive Prostate Cancer
Patrick Pilie, MD


2:30 PM - 3:00 PM

Break / Visit Exhibits


3:00 PM - 3:30 PM

Oral SERDS
Melanie Sheen, MD


3:30 PM - 4:00 PM

Redefining Curative Intent in MIBC: The Current and Future State of Bladder Preservation
Brian Halbert, MD


4:00 PM - 5:00 PM

Reception


Breakout Session

11:30 AM - 1:45 PM

Fellows Session